Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes

被引:7
作者
Marsonia, Kerul [1 ]
Chandra, Kedarisetti Kiran [1 ]
Ali, M. Hasnat [2 ]
Chhablani, Jay [3 ]
Narayanan, Raja [1 ,2 ]
机构
[1] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreo Retinal Dis, Hyderabad, India
[2] Indian Hlth Outcomes Publ Hlth & Econ Res Ctr IHO, Dept Ophthalmol, Hyderabad, India
[3] Univ Pittsburg, Dept Ophthalmol, UPMC Eye Ctr, Pittsburgh, PA USA
基金
英国惠康基金;
关键词
MacTel type 2; choroidal Neovascularization; Indian eyes; Natural history; neovascularization; Disease progression; Visual acuity; MACULAR TELANGIECTASIA TYPE-2;
D O I
10.1080/08820538.2021.1929347
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose : To evaluate the long-term natural course of macular telangiectasia Type 2, correlation with visual acuity and the incidence of Choroidal Neovascularisation (CNV) in Indian eyes. Material and methods : A Retrospective analysis of Patients with MacTel Type 2 was done over a period of 12 years with all patients having a minimum of 3 years follow up. The demographic details and ocular characteristics including best-corrected visual acuity (BCVA), fundus photography, fluorescein angiography, and optical coherence tomography images were studied in both proliferative and non-proliferative MacTel. Mixed models were used to estimate progression rates and a Kaplan Meier estimation of BCVA was plotted. Results : Eighty-two eyes of 47 patients were studied over a period of mean duration of 4.5 years (range: 3 years-8.5 years). There was no difference in the demographic characteristics between the non-proliferative MacTel and proliferative MacTel groups. There were no significant risk factors observed for progression. However, patients with retinal greying had significant risk reduction for a BCVA decline. The mean logMAR BCVA decreased from 0.25 +/- 0.25 at baseline to 0.46 +/- 0.42 by 4 years. Twenty-eight percent of the patients maintained their vision 8 years from baseline and were unlikely to progress. The incidence of CNV was 10.6% and the mean duration for the development of CNV was 2.36 years from baseline. Seventy-Three percent (11 of 15) patients with CNV had a BCVA of Conclusion : In patients of MacTel, the maximum vision loss occurred at the fourth year and then stabilized. The major cause of poor vision observed was CNV (active in 10.98% and scarred in 7.32%), foveal atrophy (10.98%) and central pigmented plaques (3.66%). The incidence of sight-threatening complication of CNV (10.6%) is likely to occur only in a minority of eyes.
引用
收藏
页码:136 / 141
页数:6
相关论文
共 12 条
  • [1] Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3
    Clemons, Traci E.
    Gillies, Mark C.
    Chew, Emily Y.
    Bird, Alan C.
    Peto, Tunde
    Wang, Jie Jin
    Mitchell, Paul
    Ramdas, Wishal D.
    Vingerling, Johannes R.
    [J]. OPHTHALMIC EPIDEMIOLOGY, 2013, 20 (02) : 109 - 113
  • [2] Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2
    Clemons, Traci E.
    Gillies, Marc C.
    Chew, Emily Y.
    Bird, Alan C.
    Peto, Tunde
    Figueroa, Maria J.
    Harrington, Molly W.
    [J]. OPHTHALMIC EPIDEMIOLOGY, 2010, 17 (01) : 66 - 73
  • [3] GASS JD, 1982, ARCH OPHTHALMOL-CHIC, V100, P769
  • [4] GASS JDM, 1993, OPHTHALMOLOGY, V100, P1536
  • [5] The Prevalence of Macular Telangiectasia Type 2 in the Beaver Dam Eye Study
    Klein, Ronald
    Blodi, Barbara A.
    Meuer, Stacy M.
    Myers, Chelsea E.
    Chew, Emily Y.
    Klein, Barbara E. K.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (01) : 55 - 62
  • [6] Long-term course in type 2 idiopathic macular telangiectasia
    Meyer-ter-Vehn, Tobias
    Herzog, Sina
    Schargus, Marc
    Goebel, Winfried
    Guthoff, Rainer
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (11) : 2513 - 2520
  • [7] SEX STEROIDS AND MACULAR TELANGIECTASIA TYPE 2
    Mueller, Simone
    Allam, Jean-Pierre
    Bunzek, Christopher G.
    Clemons, Traci E.
    Holz, Frank G.
    Charbel, Peter
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 : S61 - S66
  • [8] Peto T., 2017, RETINA-J RET VIT DIS, P1
  • [9] Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia
    Shukla, D.
    [J]. EYE, 2011, 25 (04) : 532 - 533
  • [10] TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA Long-Term Visual Prognosis and Incidence of Subretinal Neovascularization
    Shukla, Dhananjay
    Gupta, Shashank R.
    Neelakantan, Nithya
    Tiwari, Sachin
    Gupta, Sumi
    Patwardhan, Aditi R.
    Soubhya, Thayyil B.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (02): : 265 - 274